Results 1 to 10 of about 7,984 (209)

Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Dysplasia [PDF]

open access: yesIndian Pacing and Electrophysiology Journal, 2015
In this issue of 'EP Update' we summarize the recent literature on arrhythmogenic right ventricular dysplasia (ARVD). The articles have been hand picked and reviewed by the editors of IPEJ for the benefit of readers.
Johnson Francis, MD, DM, FACC, FRCP Edin, FRCP London   +1 more
doaj   +4 more sources

Arrhythmogenic right ventricular cardiomyopathy/dysplasia [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2007
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a heart muscle disease clinically characterized by life-threatening ventricular arrhythmias. Its prevalence has been estimated to vary from 1:2,500 to 1:5,000.
Basso Cristina   +2 more
doaj   +3 more sources

Arrhythmogenic Right Ventricular Dysplasia in Neuromuscular Disorders [PDF]

open access: yesClinical Medicine Insights: Cardiology, 2016
Objectives Arrhythmogenic right ventricular dysplasia (ARVD) is a rare, genetic disorder predominantly affecting the right ventricle. There is increasing evidence that in some cases, ARVD is due to mutations in genes, which have also been implicated in ...
Josef Finsterer, Claudia Stöllberger
doaj   +3 more sources

Clinical features and arrhythmic complications of patients with pediatric-onset arrhythmogenic right ventricular dysplasia [PDF]

open access: yesAnatolian Journal of Cardiology, 2019
Objective: Arrhythmogenic right ventricular dysplasia (ARVD) is a myocardial genetic disease that occurs primarily in the right ventricle. Patients with ARVD may present with severe ventricular arrhythmias, syncope, and cardiac arrest.
Fatma Sevinç Şengül   +6 more
doaj   +2 more sources

Implantable Cardioverter‐Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications [PDF]

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundArrhythmogenic right ventricular dysplasia/cardiomyopathy is characterized by ventricular arrhythmias and sudden cardiac death. Once the diagnosis is established, risk stratification to determine whether implantable cardioverter‐defibrillator ...
Gabriela M. Orgeron   +11 more
doaj   +2 more sources

Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

open access: yesIndian Pacing and Electrophysiology Journal, 2003
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is characterized by the patchy replacement of myocardium by fatty or fibrofatty tissue.
Julia H. Indik, Frank I. Marcus
doaj   +2 more sources

ATIPICIDADES EN UN CASO CON DISPLASIA ARRITMOGÉNICA DEL VENTRÍCULO DERECHO O ENFERMEDAD DE UHL / Report of an atypical case with arrhythmogenic right ventricular dysplasia or Uhl´s anomaly [PDF]

open access: yesCorSalud, 2012
ResumenLa displasia arritmogénica del ventrículo derecho es una miocardiopatía caracterizada por arritmias ventriculares malignas y anomalías estructurales progresivas, que afectan primariamente al ventrículo derecho.
Aníbal González Trujillo   +4 more
doaj   +2 more sources

Arrhythmogenic right ventricular dysplasia

open access: yesRevista Cubana de Cardiología y Cirugía Cardiovascular, 2011
The arrhythmogenic right ventricular dysplasia is a genetic base cardiomyopathy, characterizedby the substitution of the miocardic tissue by an adipose or a fibroadipose one.
Marleny Cruz Cardentey   +1 more
doaj   +1 more source

A Prenatal Case of Arrhythmogenic Right Ventricular Dysplasia [PDF]

open access: yesArquivos Brasileiros de Cardiologia, 2018
Lilian Maria Lopes   +4 more
doaj   +2 more sources

Arrhythmogenic right ventricular dysplasia [PDF]

open access: yesCurrent Treatment Options in Cardiovascular Medicine, 1999
Despite recurrences of ventricular tachycardia, patients with arrhythmogenic right ventricular dysplasia have a favorable prognosis with medical therapy. Because of the low incidence of arrhythmic death and the problems involved in identifying patients at high risk, it is difficult to evaluate the benefits of interventional therapies (ablation, surgery,
, Trohman, , Sahu
  +7 more sources

Home - About - Disclaimer - Privacy